产品详情
简单介绍：
Anti-Constitutive androstane receptor抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-Constitutive androstane receptor抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-Constitutive androstane receptor
Cat. Number:
Anti-Constitutive androstane receptor抗体KL-13972R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and
Anti-Constitutive androstane receptor抗体regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Also known as:
CAR; CAR BETA; CAR1; CARA; Constitutive activator of retinoid response; Constitutive active response; Constitutive androstane
Anti-Constitutive androstane receptor抗体receptor; MGC97144; NR1I3; NR1I3_HUMAN; Nuclear receptor subfamily 1 group I member 3; Orphan nuclear receptor MB67; Orphan nuclear receptor NR1I3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Chimpanzee, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Constitu.
●
Predicted Molecular Weight:
Anti-Constitutive androstane receptor抗体45kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be Anti-Constitutive androstane receptor抗体determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be Anti-Constitutive androstane receptor抗体determined by the end user.
kl134Bo01 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ca01 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Hu01 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Mu01 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Po01 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ra01 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Rb51 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Si01 肿瘤坏死因子β(TNFβ)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl135Bo01 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ca01 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ga01 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Hu01 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Mu01 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Po01 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ra01 血小板生成素(TPO)多克隆抗体 Polyclonal Antibody to Thrombopoietin (TPO)
kl139Ca01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Hu01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Mu01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Ra01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
